Inaugural Letter from ISCT President Jacques Galipeau | 大學教師學術專長資料庫

Dr. Galipeau is the director of the University of Wisconsin Program for Advanced Cell Therapy whose mission is to develop personalized cell therapies for immune ...

Verdu Lab. We examine the pathogenesis of chronic inflammatory disorders such as celiac disease and IBD. We also investigate host-bacterial interactions ...

2022年6月29日 — By: Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development

My laboratory research is focused on cell and biological therapy of cancer and immune ailments. We are also exploring the utility of mesenchymal stem cells ...

According to Galipeau, the premise of EPIC and its overlying mission will focus on cellular and biological therapies that use a patient’s own cells as a ...

Platelet lysate (PL) has been extensively used for the laboratory expansion of human mesenchymal stem cells (MSC) in order to avoid fetal bovine serum (FBS) ...

Culture-adapted bone marrow mesenchymal stromal cells (MSCs) deploy paracrine anti-inflammatory and tissue regenerative functionalities that can be ...

In the Galipeau lab, his current research involves identifying molecular regulators that can mitigate the host immune response mediated rejection of allografts, ...

I am a Research Project Manager for the Ha Lab at Fred Hutch and I bring 25+ years of research, project, biospecimen, and laboratory management to the team.